Enallylpropymal (Narconumal) is a
barbiturate derivative developed by Hoffman la Roche in the 1930s.[1] It has
sedative and
hypnotic effects and is considered to have a moderate abuse potential.[2]
References
^US 2072829, Schnider O, "N-Methyl-5,5-allylisopropylbarbituric acid", issued 2 March 1937, assigned to Hoffmann-La Roche Inc.
Enallylpropymal (Narconumal) is a
barbiturate derivative developed by Hoffman la Roche in the 1930s.[1] It has
sedative and
hypnotic effects and is considered to have a moderate abuse potential.[2]
References
^US 2072829, Schnider O, "N-Methyl-5,5-allylisopropylbarbituric acid", issued 2 March 1937, assigned to Hoffmann-La Roche Inc.